论文部分内容阅读
目的探讨甲氨蝶呤联合米非司酮在疤痕妊娠中的应用价值。方法本院妇产科收治的疤痕妊娠患者90例,随机分为观察组和对照组各45例。观察组和对照组患者均首先给予药物治疗,观察组患者均给予甲氨蝶呤联合米非司酮治疗,对照组患者均给予甲氨蝶呤治疗;然后两组患者均使用宫腔镜电切术进行手术治疗,将妊娠组织切除。结果观察组患者的药物治疗效果明显优于对照组患者(P<0.05);子宫切除率明显低于对照组患者(P<0.05);血HCG转阴时间和平均住院时间明显短于对照组患者(P<0.05)。结论甲氨喋呤联合米非司酮治疗疤痕妊娠具有疗效确切、子宫保全率高的特点,值得临床推广。
Objective To investigate the value of methotrexate combined with mifepristone in scar pregnancy. Methods 90 cases of pregnancy in patients with obstetrics and gynecology hospital were randomly divided into observation group and control group of 45 cases. Patients in the observation group and the control group were given the first drug treatment, the observation group were given methotrexate combined with mifepristone treatment, patients in the control group were given methotrexate treatment; then the two groups were used hysteroscopy Surgical treatment of surgery, the removal of pregnancy tissue. Results The therapeutic effect of the observation group was significantly better than that of the control group (P <0.05); the hysterectomy rate was significantly lower than that of the control group (P <0.05); the time of HCG negative conversion and the average length of hospitalization were significantly shorter than those of the control group (P <0.05). Conclusion Methotrexate combined with mifepristone treatment of scar pregnancy has the exact effect of high uterine preservation rate, worthy of clinical promotion.